RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Bullwaves Prime vs Crypto Fund Trader

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

BWVP

Bullwaves Prime

CRFT

Crypto Fund Trader

EST. 2022

BULLWAVES PRIME

METRIC

CRYPTO FUND TRADER

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

$200,000

—

MIN COST

$5,000

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

BULLWAVES PRIME DETAILS

STEPS: -phase

CRYPTO FUND TRADER DETAILS

STEPS: -phase
MARKETS: Crypto
PLATFORMS: MT5

Bullwaves Prime PROS

+No data is available to identify any pros for Bullwaves Prime at this time.
+No platform or market information is provided to assess trading conditions.
+No funding or cost data is available to compare against industry benchmarks.
+No profit split or payout data exists to evaluate trader compensation.

Bullwaves Prime CONS

−No data whatsoever is available for Bullwaves Prime, making any evaluation impossible.
−Complete absence of key metrics such as drawdown, profit split, and funding is a significant transparency concern.
−Traders have no basis for comparison against industry averages with zero data disclosed.

Crypto Fund Trader PROS

+Crypto-focused offering provides niche market access unavailable at most prop firms
+Based in Switzerland, a well-regulated and reputable financial hub
+Founded in 2022, indicating an established operational track record
+Offers MT5, a widely used and trusted trading platform

Crypto Fund Trader CONS

−Min challenge cost of $5,000 is vastly higher than the industry average of $186.7
−Max funding of $200,000 is well below the industry average of $839,272.70
−No profit split, drawdown, or profit target data provided, limiting informed comparison

PROPDNA VERDICT